Gecko Biomedical, a Paris, France-based medical device company developing innovative polymers to support tissue healing, received an interest-free loan of €1.4m.
The funds are part of Bpifrance’s support of innovation through its interest-free loan program (Prêt à Taux Zéro pour l’Innovation -PTZI), providing repayable advances to encourage the development of innovative products.
The company will use the funds to advance its bio-inspired surgical adhesive solutions via clinical trials in Europe in order to obtain CE Mark in the first half of 2017.
Led by Christophe Bancel, Chief Executive Officer, Gecko Biomedical is dedicated to the rapid development and commercialization of a unique biopolymers platform based on proprietary biopolymers.
Its first product (GB-02) is an innovative polymer for tissue healing, targeting cardiovascular reconstruction as an initial indication. The structure of GB-02 allows customization for various applications and tissues.
The company’s technologies are derived from research and intellectual property from the laboratories of Pr Robert Langer (MIT) and Pr Jeff Karp (Brigham and Women’s Hospital), who co-founded the company in 2013, alongside Bancel and Bernard Gilly from the iBionext Network.